{"DataElement":{"publicId":"3431714","version":"1","preferredName":"Soft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for soft tissue sarcoma.","longName":"3431341v1.0:3431453v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3431341","version":"1","preferredName":"Soft Tissue Sarcoma Stage Grouping","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2963681v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2963681","version":"1","preferredName":"Soft Tissue Sarcoma","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","longName":"C9306","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79667DFC-075B-3EB9-E040-BB89AD43658B","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"ONEDATA","dateModified":"2009-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE0815A-B43A-65C9-E040-BB89AD4344F0","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"TAYLORT","dateModified":"2019-03-29","changeDescription":"3-29-19 Transferred DEC ownership from NCIP to NCI Standards; tmt. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3431453","version":"1","preferredName":"Soft Tissue Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3431453v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IIA","valueDescription":"Stage IIA Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431461","version":"1","preferredName":"Stage IIA Soft Tissue Sarcoma","longName":"3431461","preferredDefinition":"Stage IIA includes: (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G2: Grade 2.  G3: Grade 3. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Soft Tissue Sarcoma AJCC v7","conceptCode":"C8581","definition":"Stage IIA includes: (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G2: Grade 2.  G3: Grade 3. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8AEE-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8B07-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431463","version":"1","preferredName":"Stage IB Soft Tissue Sarcoma","longName":"3431463","preferredDefinition":"Stage IB includes: (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G1: Grade 1.  GX: Grade cannot be assessed. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Soft Tissue Sarcoma AJCC v7","conceptCode":"C8580","definition":"Stage IB includes: (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G1: Grade 1.  GX: Grade cannot be assessed. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8B14-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8B2D-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431465","version":"1","preferredName":"Stage IA Soft Tissue Sarcoma","longName":"3431465","preferredDefinition":"Stage IA includes: (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G1: Grade 1.  GX: Grade cannot be assessed. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Soft Tissue Sarcoma AJCC v7","conceptCode":"C8583","definition":"Stage IA includes: (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX).  T1a: Superficial tumor 5 cm or less in greatest dimension.  T1b: Deep tumor 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G1: Grade 1.  GX: Grade cannot be assessed. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8B3A-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8B53-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8A6F-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431455","version":"1","preferredName":"Stage IV Soft Tissue Sarcoma","longName":"3431455","preferredDefinition":"Stage IV includes: Any T, Any N, M1, Any G.  M1: Distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Soft Tissue Sarcoma AJCC v7","conceptCode":"C8586","definition":"Stage IV includes: Any T, Any N, M1, Any G.  M1: Distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8A7C-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8A95-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431457","version":"1","preferredName":"Stage III Soft Tissue Sarcoma","longName":"3431457","preferredDefinition":"Stage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis.  G3: Grade 3.  There is no T2a for the pathologic group. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Soft Tissue Sarcoma AJCC v7","conceptCode":"C8585","definition":"Stage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis.  G3: Grade 3.  There is no T2a for the pathologic group. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8AA2-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8ABB-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3431459","version":"1","preferredName":"Stage IIB Soft Tissue Sarcoma","longName":"3431459","preferredDefinition":"Stage IIB includes: (T2a, N0, M0, G2); (T2b, N0, M0, G2).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G2: Grade 2.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Soft Tissue Sarcoma AJCC v7","conceptCode":"C8582","definition":"Stage IIB includes: (T2a, N0, M0, G2); (T2b, N0, M0, G2).  T2a: Superficial tumor more than 5 cm in greatest dimension.  T2b: Deep tumor more than 5 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  G2: Grade 2.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8AC8-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE19A81-8AE1-1C57-E040-BB89AD430A04","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3431452","version":"1","preferredName":"Soft Tissue Sarcoma TNM Finding v7 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88449:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma TNM Finding v7","conceptCode":"C88449","definition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8A46-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE19A81-8A57-1C57-E040-BB89AD430A04","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434442","version":"1","longName":"Soft Tissue Sarcoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000420","version":"1","longName":"Soft Tissue Sarcoma","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"STS_AJCC7_DZ_STG","type":"Context Short Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BCE48D59-B647-1F93-E040-BB89AD437852","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}